SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press release on Financial Results09-02-2023
SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press release on Financial ResultsSMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor PresentationSMS PHARMACEUTICALS LTD. - 532815 - Financial Results For The Quarter Ended 31St December, 2022
Financial Results for the quarter ended 31st December, 2022SMS PHARMACEUTICALS LTD. - 532815 - Board Meeting Outcome for Outcome Of Board Meeting And Financial Results
Outcome of Board Meeting held on 09th February, 2023SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Investor's Conference CallSMS PHARMACEUTICALS LTD. - 532815 - Board Meeting Intimation for Notice Of Board Meeting & Intimation
SMS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2023 ,inter alia, to consider and approve Notice of Board Meeting & IntimationSMS PHARMACEUTICALS LTD. - 532815 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018SMS PHARMACEUTICALS LTD. - 532815 - Closure of Trading Window
Intimation of closure of Trading WindowSMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Transcript of the Conference Call held on 17th November, 2022.SMS PHARMACEUTICALS LTD. - 532815 - Disclosure Of Related Party Transactions For The Half Year Ended 30Th September, 2022
Disclosure of Related Party Transactions for the half year ended 30th September, 2022